Scientific letter
Tofacitinib for the treatment of inflammatory condition of the ileoanal pouch refractory to infliximab
Tofacitinib para el tratamiento de la afección inflamatoria del reservorio refractaria a infliximab
Read
42
Timeswas read the article
0
Total PDF
42
Total HTML
Share statistics
array:24 [ "pii" => "S2444382423001268" "issn" => "24443824" "doi" => "10.1016/j.gastre.2023.07.002" "estado" => "S300" "fechaPublicacion" => "2023-10-01" "aid" => "1977" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2022" "documento" => "article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2023;46:629-30" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0210570522002096" "issn" => "02105705" "doi" => "10.1016/j.gastrohep.2022.08.005" "estado" => "S300" "fechaPublicacion" => "2023-10-01" "aid" => "1977" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2023;46:629-30" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científica</span>" "titulo" => "Tofacitinib para el tratamiento de la afección inflamatoria del reservorio refractaria a infliximab" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "629" "paginaFinal" => "630" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Tofacitinib for the treatment of inflammatory condition of the ileoanal pouch refractory to infliximab" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1611 "Ancho" => 2925 "Tamanyo" => 227964 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evolución de los valores de hemoglobina (g/dl) en los dos últimos años (enero 2020-mayo-2022).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marta Fortuny, Laura Gutiérrez-Rios, Eva Vayreda, Míriam Mañosa, Eugeni Domènech" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Marta" "apellidos" => "Fortuny" ] 1 => array:2 [ "nombre" => "Laura" "apellidos" => "Gutiérrez-Rios" ] 2 => array:2 [ "nombre" => "Eva" "apellidos" => "Vayreda" ] 3 => array:2 [ "nombre" => "Míriam" "apellidos" => "Mañosa" ] 4 => array:2 [ "nombre" => "Eugeni" "apellidos" => "Domènech" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2444382423001268" "doi" => "10.1016/j.gastre.2023.07.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382423001268?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570522002096?idApp=UINPBA00004N" "url" => "/02105705/0000004600000008/v1_202309280830/S0210570522002096/v1_202309280830/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2444382423001487" "issn" => "24443824" "doi" => "10.1016/j.gastre.2022.10.017" "estado" => "S300" "fechaPublicacion" => "2023-10-01" "aid" => "2009" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2023;46:631-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Relationship between ustekinumab trough concentrations and both clinical and biological remission in patients with Crohn's disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "631" "paginaFinal" => "632" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Relación entre las concentraciones mínimas de ustekinumab y la remisión clínica y biológica en pacientes con enfermedad de Crohn" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1983 "Ancho" => 3174 "Tamanyo" => 209025 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A. Quartile distribution of ustekinumab levels according clinical remission. B. Ustekinumab levels according clinical remission. C. Ustekinumab levels according biological remission. D. Ustekinumab levels according clinical remission in patients without intestinal resection surgery. NS: not significant.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Francisco Ángel Lao Domínguez, María José Fobelo Lozano, Antonio Gutiérrez Pizarraya, Manuel Castro Fernández" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Francisco Ángel" "apellidos" => "Lao Domínguez" ] 1 => array:2 [ "nombre" => "María José" "apellidos" => "Fobelo Lozano" ] 2 => array:2 [ "nombre" => "Antonio" "apellidos" => "Gutiérrez Pizarraya" ] 3 => array:2 [ "nombre" => "Manuel" "apellidos" => "Castro Fernández" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382423001487?idApp=UINPBA00004N" "url" => "/24443824/0000004600000008/v2_202311101346/S2444382423001487/v2_202311101346/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2444382423001463" "issn" => "24443824" "doi" => "10.1016/j.gastre.2022.08.009" "estado" => "S300" "fechaPublicacion" => "2023-10-01" "aid" => "1967" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2023;46:628-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "A challenging alpha-fetoprotein after liver transplantation" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "628" "paginaFinal" => "629" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Un diagnóstico desafiante de alfafetoproteína elevada en paciente trasplantado hepático" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1017 "Ancho" => 1256 "Tamanyo" => 260175 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Abdominal computed tomography scan revealed gastric parietal thickening and a luminal protrusion suggestive of malignancy. (B) Esophagogastroduodenoscopy revealed a large protruding ulcerated lesion extending along the smaller curvature of antrum and body. (C) Histopathological examination revealed a solid neoplasia forming glandular structures consistent with adenocarcinoma. (D) Immunohistochemistry showed strong positivity for alpha-fetoprotein in neoplastic cells.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Emanuel Dias, Hélder Cardoso, Eduardo Rodrigues-Pinto, Raquel Portugal, Guilherme Macedo" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Emanuel" "apellidos" => "Dias" ] 1 => array:2 [ "nombre" => "Hélder" "apellidos" => "Cardoso" ] 2 => array:2 [ "nombre" => "Eduardo" "apellidos" => "Rodrigues-Pinto" ] 3 => array:2 [ "nombre" => "Raquel" "apellidos" => "Portugal" ] 4 => array:2 [ "nombre" => "Guilherme" "apellidos" => "Macedo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382423001463?idApp=UINPBA00004N" "url" => "/24443824/0000004600000008/v2_202311101346/S2444382423001463/v2_202311101346/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Tofacitinib for the treatment of inflammatory condition of the ileoanal pouch refractory to infliximab" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "629" "paginaFinal" => "630" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Marta Fortuny, Laura Gutiérrez-Rios, Eva Vayreda, Míriam Mañosa, Eugeni Domènech" "autores" => array:5 [ 0 => array:3 [ "nombre" => "Marta" "apellidos" => "Fortuny" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Laura" "apellidos" => "Gutiérrez-Rios" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Eva" "apellidos" => "Vayreda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Míriam" "apellidos" => "Mañosa" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 4 => array:4 [ "nombre" => "Eugeni" "apellidos" => "Domènech" "email" => array:1 [ 0 => "eugenidomenech@gmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tofacitinib para el tratamiento de la afección inflamatoria del reservorio refractaria a infliximab" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1620 "Ancho" => 2933 "Tamanyo" => 269388 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0035" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evolution of haemoglobin values (g/dl) in the last two years (January 2020–May-2022).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Up to 5%–15% of patients with ulcerative colitis (UC) require surgical treatment, with proctocolectomy with ileoanal pouch being the technique of choice. Pouchitis is its most common complication. Pouchitis includes a range of situations that remain ill-defined, ranging from classical pouchitis to Crohn's disease of the pouch.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The increasing incidence of this complication and the risks and loss of quality of life associated with the extraction of the pouch have increased interest in finding therapeutic alternatives in this situation.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> We present the case of a patient with a pouch and chronic iron deficiency anaemia secondary to patchy inflammatory involvement of the pouch who received rescue treatment with tofacitinib after failure of treatment with TNF inhibitors.</p><p id="par0010" class="elsevierStylePara elsevierViewall">This was a 48-year-old male patient with left-sided UC of 18 years of evolution requiring proctocolectomy with pouch due to refractory disease. Five years after surgery, there was onset of rectorrhagia and severe iron deficiency anaemia. Hence, a pouchoscopy revealed deep, friable ulcers in the pouch, causing stenosis of the access to afferent and efferent loops. Other causes of anaemia were ruled out (negative coeliac disease study, gastroscopy and capsule endoscopy without findings) and, given the characteristics of the lesions, it was decided to start treatment with oral budesonide with no clinical response, so combined treatment with infliximab (5<span class="elsevierStyleHsp" style=""></span>mg/kg every eight weeks) and azathioprine was started. Despite this, the patient required high-dose intravenous iron repletion and even periodic blood transfusion, with no endoscopic improvement, so infliximab was intensified to every six weeks. However, in successive endoscopies, ulcerated stenosis of the access orifice to afferent and efferent loops persisted, so local injection of infliximab and antibiotic therapy with metronidazole 500<span class="elsevierStyleHsp" style=""></span>mg/every eight hours for four weeks was administered without success. Given the patient's reluctance to have the pouch removed and the lack of therapeutic alternatives in this situation, treatment with infliximab was maintained for 10 years, with a progressive increase in the requirement for intravenous iron therapy and blood transfusions in the last two years (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">After another pouchoscopy in which no changes were observed, the anaemia was exacerbated with haemoglobin of 7<span class="elsevierStyleHsp" style=""></span>g/dl. Resection of the pouch and end ileostomy were considered, but given the patient's reluctance to undergo further surgery, rescue treatment with tofacitinib was agreed on, following the guidelines approved for UC (10<span class="elsevierStyleHsp" style=""></span>mg every 12<span class="elsevierStyleHsp" style=""></span>h for eight weeks, followed by 5<span class="elsevierStyleHsp" style=""></span>mg/12<span class="elsevierStyleHsp" style=""></span>h), with the patient presenting with frank clinical improvement (only some isolated rectorrhagia). At five months after the start of treatment, the anaemia resolved for the first time in the last 15 months (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). At one year of follow-up, only 1<span class="elsevierStyleHsp" style=""></span>g of intravenous iron was required without transfusion support, although there was no endoscopic improvement.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Pouchitis occurs in up to 30% of patients with pouches. The therapeutic requirements of pouchitis are high, with up to 80% of patients requiring biologics and 15%–30%, surgery. However, TNF inhibitors have been shown to be effective in only half of patients with pouchitis and this, together with the desire of most patients to avoid having to have the pouch removed, requires a search for effective therapeutic alternatives. Although we do not have controlled clinical trials comparing the efficacy of tofacitinib (JAK1 and JAK3 inhibitor, approved for UC without response to conventional therapy) with other drugs, a recent meta-analysis equates it in efficacy to other biologic therapies in the treatment of UC. Additionally, high response rates to tofacitinib have been reported in patients with UC refractory to biologic treatment. In this scenario, the lack of controlled clinical trials in treating pouchitis has traditionally demanded the use of drugs that have been effective in ulcerative colitis, so the use of tofacitinib seems reasonable. To date, there are only nine cases of chronic refractory pouchitis treated with tofacitinib in the literature.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3–5</span></a></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1620 "Ancho" => 2933 "Tamanyo" => 269388 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0035" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evolution of haemoglobin values (g/dl) in the last two years (January 2020–May-2022).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Akiyama" 1 => "J.E. Ollech" 2 => "V. Rai" 3 => "L.R. Glick" 4 => "Y. Yi" 5 => "C. Traboulsi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2021.02.010" "Revista" => array:6 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2022" "volumen" => "20" "paginaInicial" => "293" "paginaFinal" => "302.e9" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33549868" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of pouchitis, Crohn’s disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Shen" 1 => "G.S. Kochhar" 2 => "D.T. Rubin" 3 => "S.V. Kane" 4 => "U. Navaneethan" 5 => "C.N. Bernstein" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2468-1253(21)00214-4" "Revista" => array:6 [ "tituloSerie" => "Lancet Gastroenterol Hepatol" "fecha" => "2022" "volumen" => "7" "paginaInicial" => "69" "paginaFinal" => "95" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34774224" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.S. Dalal" 1 => "K. Bains" 2 => "J. Marcus" 3 => "E.L. McClure" 4 => "J.R. Allegretti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ibd/izac147" "Revista" => array:3 [ "tituloSerie" => "Inflamm Bowel Dis" "fecha" => "2022" "paginaInicial" => "izac147" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tofacitinib in the Treatment of Crohn’s-Like Disease of the Pouch" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C.M. Bauer" 1 => "E.L. Barnes" 2 => "H.H. Herfarth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14309/ajg.0000000000000801" "Revista" => array:6 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2020" "volumen" => "115" "paginaInicial" => "2116" "paginaFinal" => "2117" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32740085" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of refractory chronic pouchitis successfully treated with tofacitinib" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Okano" 1 => "N. Yoshimura" 2 => "M. Sako" 3 => "M. Takazoe" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12328-020-01108-5" "Revista" => array:6 [ "tituloSerie" => "Clin J Gastroenterol" "fecha" => "2020" "volumen" => "13" "paginaInicial" => "560" "paginaFinal" => "563" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32130659" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/24443824/0000004600000008/v2_202311101346/S2444382423001268/v2_202311101346/en/main.assets" "Apartado" => array:4 [ "identificador" => "77930" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letter" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/24443824/0000004600000008/v2_202311101346/S2444382423001268/v2_202311101346/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382423001268?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 2 | 0 | 2 |
| 2024 August | 4 | 0 | 4 |
| 2024 June | 1 | 0 | 1 |
| 2024 March | 5 | 0 | 5 |
| 2024 February | 12 | 0 | 12 |
| 2024 January | 6 | 0 | 6 |
| 2023 December | 5 | 0 | 5 |
| 2023 November | 1 | 0 | 1 |
| 2023 October | 4 | 0 | 4 |
| 2023 September | 2 | 0 | 2 |
